The MD Anderson Manual of Medical Oncology

Authoritative, hands-on desk reference for the practicing oncologist—from the leader in the field of cancer management and treatment

The MD Anderson Manual of Medical Oncology details the personalized multidisciplinary approach to cancer management and treatment of common and rare cancers pioneered by The University of Texas MD Anderson Cancer Center. Its pragmatic presentation can provide valuable insights at any stage of your career.

This completely updated third edition reflects the most recent advancements, including expanded coverage of the rapidly evolving area of biological and immune therapies of cancer, many developed at MD Anderson. Itemphasizes and discusses continuing developments in diagnostic procedures, which include the incorporation of new molecular markers and revised staging systems. It also reinforces how imaging and molecular profiling can prevent administration of overly aggressive, toxic treatment regimens or invasive surgery to treat superficial or indolent tumors.

To help you quickly assess cancer management options, every chapter includes numerous tables, diagrams, imaging photographs, and prescriptive advice. Evidence-based treatment algorithms in the form of flowcharts and diagrams shaped by the clinical experience of MD Anderson’s world-class faculty enhance the text.

The third edition features important new chapters on key topics such as:

· Pediatric Cancers

· Molecular Biomarkers and Cancer

· Immuno-Oncology

· Targeted Therapies in Cancer

· Onco-Cardiology

· Pulmonary Complications of Cancer Therapy

· Applied Biostatistics

Offering the perfect balance of narrative text, summary tables, and clinical photographs (many in full color), there is truly not a more accessible, up-to-date, or authoritative clinician’s guide to the medical management of patients with cancer and its complications thanThe MD Anderson Manual of Medical Oncology.

Hagop M. Kantarjian, MD is Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Department Chair, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Associate Vice President for Global Academic Programs, The University of Texas MD Anderson Cancer Center, Houston, TX Kelcie Margaret Kana - Research Chair, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Robert Wolff, MD is Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, Deputy Division Head, Clinical and Educational Affairs, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, Director, Educational Programs, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, Sheikh Zayed Bin Sultan Al Nahyan Distinguished University Chair of Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, Department Chair ad interim, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX